Breaking News Instant updates and real-time market news.

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11

Fabrinet President Gill sells 12.9K shares of common stock

In a regulatory filing, Fabrinet disclosed that its President Harpal Gill sold 12.9K shares of common stock on November 15th. The total transaction size was $784K.

  • 12

    Dec

FN Fabrinet
$60.82

0.84 (1.40%)

08/09/19
NEED
08/09/19
NO CHANGE
Target $70
NEED
Buy
Fabrinet price target raised to $70 from $62 at Needham
Needham analyst Alex Henderson raised his price target on Fabrinet to $70 and kept his Buy rating ahead of its earnings on August 19th. The analyst expects a "strong print and guide", since "virtually every company" in the Optical space reported stronger than expected results this quarter. Henderson adds that the concerns related to Fabrinet's exposure to Huawei also appear to be "overdone".
08/20/19
PIPR
08/20/19
NO CHANGE
Target $64
PIPR
Overweight
Fabrinet price target lowered to $64 from $69 at Piper Jaffray
Piper Jaffray analyst Troy Jensen lowered his price target on Fabrinet (FN) to $64 after its below-consensus Q1 outlook related to concerns about the industrial laser market remaining weak. The analyst also points to the Huawei ban hampering sales for component supplies. Jensen still keeps his Overweight rating, stating that Fabrinet remains "one of the better ways to play the optical market" and forecasting more sustained strength in Telco optics and a ramp in Infinera (INFN) sales.
09/30/19
NORL
09/30/19
UPGRADE
Target $57
NORL
Outperform
Fabrinet upgraded to Outperform from Market Perform at Northland
Northland analyst Tim Savageaux upgraded Fabrinet (FN) to Outperform from Market Perform and raised its price target to $57 from $44 saying increased revenues at a healthier Infinera (INFN), SiP growth at Intel (INTC), and positives from LITE telecom strength offset consolidation headwinds in the group. Savageaux also sees upside from demand strength, margin benefits from rapid manufacturing transition to FN, and the launch of coherent edge/access focused XR Optics.
11/05/19
PIPR
11/05/19
NO CHANGE
Target $68
PIPR
Overweight
Fabrinet price target raised to $68 from $64 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Fabrinet to $68 from $64 saying the company reported "strong" September quarter results with revenue and earnings beating expectations, and with guidance for the December quarter also above consensus estimates. The analyst adds that with telecom driving the beat and datacom "looking to have bottomed out," he continues to view Fabrinet as one of the better ways to play the optical market. He reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

PLCE

Children's Place

$70.67

0.68 (0.97%)

07:29
12/11/19
12/11
07:29
12/11/19
07:29
Hot Stocks
Children's Place down 17% to $58.20 after lowering FY19 guidance »

The company's Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BBSI

Barrett Business

$89.45

1.85 (2.11%)

07:29
12/11/19
12/11
07:29
12/11/19
07:29
Initiation
Barrett Business initiated  »

Barrett Business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MA

MasterCard

$288.56

-0.48 (-0.17%)

07:28
12/11/19
12/11
07:28
12/11/19
07:28
Recommendations
MasterCard analyst commentary  »

MasterCard price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROK

Rockwell Automation

$199.78

0.89 (0.45%)

07:28
12/11/19
12/11
07:28
12/11/19
07:28
Upgrade
Rockwell Automation rating change  »

Rockwell Automation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBT

Welbilt

$16.32

-0.14 (-0.85%)

07:27
12/11/19
12/11
07:27
12/11/19
07:27
Downgrade
Welbilt rating change  »

Welbilt downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCI

Crown Castle

$134.00

-1.93 (-1.42%)

07:26
12/11/19
12/11
07:26
12/11/19
07:26
Conference/Events
Crown Castle management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

THDDY

TV Asahi

$0.00

(0.00%)

07:22
12/11/19
12/11
07:22
12/11/19
07:22
Initiation
TV Asahi initiated  »

TV Asahi initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEM

Agnico Eagle

$59.19

-0.11 (-0.19%)

07:21
12/11/19
12/11
07:21
12/11/19
07:21
Upgrade
Agnico Eagle rating change  »

Agnico Eagle upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOLD

Barrick Gold

07:21
12/11/19
12/11
07:21
12/11/19
07:21
Upgrade
Barrick Gold rating change  »

Barrick Gold upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FQVLF

First Quantum Minerals

$0.00

(0.00%)

07:21
12/11/19
12/11
07:21
12/11/19
07:21
Downgrade
First Quantum Minerals rating change  »

First Quantum Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FJTNY

Fuji Media

$0.00

(0.00%)

07:21
12/11/19
12/11
07:21
12/11/19
07:21
Initiation
Fuji Media initiated  »

Fuji Media initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVFM

Evofem

$6.30

0.03 (0.48%)

07:19
12/11/19
12/11
07:19
12/11/19
07:19
Recommendations
Evofem analyst commentary  »

Evofem price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PB

Prosperity Bancshares

$70.40

-0.31 (-0.44%)

07:18
12/11/19
12/11
07:18
12/11/19
07:18
Downgrade
Prosperity Bancshares rating change  »

Prosperity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CASY

Casey's General Stores

$158.77

-16.56 (-9.45%)

07:17
12/11/19
12/11
07:17
12/11/19
07:17
Recommendations
Casey's General Stores analyst commentary  »

Casey's General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAG

IAMGold

$3.40

-0.05 (-1.45%)

07:16
12/11/19
12/11
07:16
12/11/19
07:16
Hot Stocks
IAMGold increases interest in Nelligan project by 24% for C$2.35M »

Vanstar Mining Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$1,250.39

79.085 (6.75%)

07:16
12/11/19
12/11
07:16
12/11/19
07:16
Conference/Events
AutoZone management to meet with Morgan Stanley »

Group Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 18

    Dec

PRQR

ProQR Therapeutics

$9.09

0.44 (5.09%)

07:13
12/11/19
12/11
07:13
12/11/19
07:13
Hot Stocks
ProQR Therapeutics doses first patient in Phase 1/2 Aurora trial of QR-1123 »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTAI

BioXcel Therapeutics

$6.08

-0.07 (-1.14%)

07:12
12/11/19
12/11
07:12
12/11/19
07:12
Hot Stocks
BioXcel Therapeutics to expand BXCL701 study into multiple advanced solid tumors »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAA

Plains All American

$18.01

0.49 (2.80%)

07:12
12/11/19
12/11
07:12
12/11/19
07:12
Recommendations
Plains All American analyst commentary  »

Plains All American price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

WSR

Whitestone REIT

$13.66

-0.1 (-0.73%)

07:11
12/11/19
12/11
07:11
12/11/19
07:11
Hot Stocks
Whitestone REIT acquires Las Colina Village, terms not disclosed »

Whitestone REIT acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFIN

American Finance Trust

$14.53

-0.15 (-1.02%)

07:10
12/11/19
12/11
07:10
12/11/19
07:10
Conference/Events
American Finance Trust management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AHCO

AdaptHealth

$10.09

0.19 (1.92%)

07:10
12/11/19
12/11
07:10
12/11/19
07:10
Initiation
AdaptHealth initiated  »

AdaptHealth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIE

Viela Bio

$28.00

2 (7.69%)

07:10
12/11/19
12/11
07:10
12/11/19
07:10
Hot Stocks
Viela Bio initiates Phase 2b trial of VIB4920 in Sjogren's syndrome »

Viela Bio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XCUR

Exicure

$2.99

0.115 (4.01%)

07:09
12/11/19
12/11
07:09
12/11/19
07:09
Hot Stocks
Exicure announces update from AST-008 trial, to enroll patients in Phase 2 study »

Exicure announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCRX

BioCryst

$2.86

0.26 (10.00%)

07:08
12/11/19
12/11
07:08
12/11/19
07:08
Hot Stocks
BioCryst submits NDA for oral, once daily berotralstat for HAE attacks »

BioCryst Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.